Transforming Growth Factor-beta1 Up-regulation of Human Alpha(1)(I) Collagen is Mediated by Sp1 and Smad2 Transacting Factors
Overview
Molecular Biology
Affiliations
Hepatic fibrosis results from excessive deposition of type I collagen. The roles of Smads in mediating the effect of transforming growth factor-beta1 (TGFbeta1) on activation of the alpha(1)(I) collagen promoter were determined. Smads bind in association with Sp1 to the CC(GG)-rich TGFbeta1 responsive element of the promoter that lacks the classical Smad recognition element, and enhance binding of Sp1. In transfection experiments, TGFbeta1 activated a proximal promoter, but not promoters mutated at sites that prevented Sp1 binding. Sp1 alone or the combination of Smad2 and Smad4 activated the promoter in transfected human LX-2 stellate cells. Sp1 or Smad2 knockdowns with siRNAs prevented the effect of TGFbeta1 in enhancing the promoter. In conclusion, this study shows that Smads bind in association with Sp1 to the CC(GG)-rich TGFbeta1 responsive element of the human alpha(1)(I) collagen promoter that lacks the classical Smad recognition element, thus enhancing the binding of Sp1 and in this manner activating the collagen promoter.
Banerjee P, Das A, Singh K, Khanna S, Sen C, Roy S Sci Rep. 2024; 14(1):3257.
PMID: 38331988 PMC: 10853180. DOI: 10.1038/s41598-024-53424-2.
MYCT1 attenuates renal fibrosis and tubular injury in diabetic kidney disease.
Li X, Fan Q, Ma T, Liu C, Shi H, Sun Y iScience. 2023; 26(9):107609.
PMID: 37664593 PMC: 10470386. DOI: 10.1016/j.isci.2023.107609.
Sehgal M, Jakhete S, Manekar A, Sasikumar S Heliyon. 2022; 8(8):e09773.
PMID: 36061031 PMC: 9434059. DOI: 10.1016/j.heliyon.2022.e09773.
Engrailed 1 coordinates cytoskeletal reorganization to induce myofibroblast differentiation.
Gyorfi A, Matei A, Fuchs M, Liang C, Rius Rigau A, Hong X J Exp Med. 2021; 218(9).
PMID: 34259830 PMC: 8288503. DOI: 10.1084/jem.20201916.
ZEB1 Mediates Fibrosis in Corneal Endothelial Mesenchymal Transition Through SP1 and SP3.
Lee J, Jung E, Gestoso K, Heur M Invest Ophthalmol Vis Sci. 2020; 61(8):41.
PMID: 32721022 PMC: 7425726. DOI: 10.1167/iovs.61.8.41.